Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
LGALS1 overexpression + LAG3 overexpression
i
Other names:
LAG3, Lymphocyte Activating 3, Lymphocyte Activation Gene 3 Protein, Lymphocyte-Activation Gene 3, CD223 Antigen, CD223, LAG-3, FDC
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3902
;
3956
Related biomarkers:
Expression
Mutation
Others
‹
LAG3 expression (6)
LAG3 overexpression (5)
ITGAM overexpression + LAG3 overexpression (1)
LAG3 expression + CTAG1B expression (1)
LAG3 positive + CD4 positive (1)
PD-L1 overexpression + LAG3 expression + CTAG1B expression (1)
LGALS1 underexpression (1)
PD-L1 expression + LAG3 expression (0)
LAG3 expression (6)
LAG3 overexpression (5)
ITGAM overexpression + LAG3 overexpression (1)
LAG3 expression + CTAG1B expression (1)
LAG3 positive + CD4 positive (1)
PD-L1 overexpression + LAG3 expression + CTAG1B expression (1)
LGALS1 underexpression (1)
PD-L1 expression + LAG3 expression (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
LGALS1 overexpression + LAG3 overexpression
Chronic Lymphocytic Leukemia
LGALS1 overexpression + LAG3 overexpression
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
LGALS1 overexpression + LAG3 overexpression
Chronic Lymphocytic Leukemia
LGALS1 overexpression + LAG3 overexpression
Chronic Lymphocytic Leukemia
OTX-008
Sensitive: C3 – Early Trials
OTX-008
Sensitive
:
C3
OTX-008
Sensitive: C3 – Early Trials
OTX-008
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.